Abstract
Oculogyric crisis (OGC) is an acute dystonia which can occur after initiation of antipsychotic treatment. Stereotypic paroxysmal psychiatric symptoms have been described along with OGC that resolve spontaneously when the later remits. We report a case of tardive OGC associated with zuclopenthixol in which there were associated paroxysmal auditory pseudohallucinations.
Keywords: Oculogyric crisis, dystonia, tardive, stereotypic paroxysmal psychiatric symptoms, pseudohallucinations, zuclopenthixol, antipsychotics, ocular pain, agitation, malaise, restlessness, anxiety, schizoid, cognitive, dopaminergic, cholinergic, GABA-ergic, neurobiology, FSC
Current Drug Safety
Title: Stereotyped Paroxysmal Psychiatric Symptoms During Oculogyric Crisis or ‘Cognitive Dystonia’: A Case Report
Volume: 6 Issue: 1
Author(s): Samir Kumar Praharaj, Sujit Sarkhel and Sayeed Akhtar
Affiliation:
Keywords: Oculogyric crisis, dystonia, tardive, stereotypic paroxysmal psychiatric symptoms, pseudohallucinations, zuclopenthixol, antipsychotics, ocular pain, agitation, malaise, restlessness, anxiety, schizoid, cognitive, dopaminergic, cholinergic, GABA-ergic, neurobiology, FSC
Abstract: Oculogyric crisis (OGC) is an acute dystonia which can occur after initiation of antipsychotic treatment. Stereotypic paroxysmal psychiatric symptoms have been described along with OGC that resolve spontaneously when the later remits. We report a case of tardive OGC associated with zuclopenthixol in which there were associated paroxysmal auditory pseudohallucinations.
Export Options
About this article
Cite this article as:
Kumar Praharaj Samir, Sarkhel Sujit and Akhtar Sayeed, Stereotyped Paroxysmal Psychiatric Symptoms During Oculogyric Crisis or ‘Cognitive Dystonia’: A Case Report, Current Drug Safety 2011; 6 (1) . https://dx.doi.org/10.2174/157488611794479982
DOI https://dx.doi.org/10.2174/157488611794479982 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting RGD Recognizing Integrins: Drug Development, Biomaterial Research, Tumor Imaging and Targeting
Current Pharmaceutical Design Computer Aided Systems for Diabetic Retinopathy Detection Using Digital Fundus Images: A Survey
Current Medical Imaging Stem Cell-based Tissue Engineering Approaches for Musculoskeletal Regeneration
Current Pharmaceutical Design Targeting Brain Cancer Cells by Nanorobot, a Promising Nanovehicle: New Challenges and Future Perspectives
CNS & Neurological Disorders - Drug Targets Noradrenaline in Parkinsons Disease: From Disease Progression to Current Therapeutics
Current Medicinal Chemistry Blood-Brain Barrier Alterations in MDX Mouse, An Animal Model of the Duchenne Muscular Dystrophy
Current Neurovascular Research Contemporary Treatment of Amyloid Heart Disease
Current Pharmaceutical Design New Molecular Avenues in Parkinson ’ s Disease Therapy
Current Topics in Medicinal Chemistry Clinical Application of the Vestibular Stimulation Effect on Balance Disorders with Dementia
Current Alzheimer Research Molecular Dynamics Simulations, Challenges and Opportunities: A Biologist’s Prospective
Current Protein & Peptide Science The Therapeutic Role of Electroencephalography in Deep Brain Stimulation in Intractable Epilepsy: A Recent Perspective
Recent Patents and Topics on Imaging (Discontinued) Roles of p97-Associated Deubiquitinases in Protein Quality Control at the Endoplasmic Reticulum
Current Protein & Peptide Science The Challenges of Blood Pressure Control in Dialysis Patients
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Radiation-Induced Neuroinflammation and Radiation Somnolence Syndrome
CNS & Neurological Disorders - Drug Targets Treatment of the Motor and Non-Motor Symptoms in Parkinson's Disease According to Cluster Symptoms Presentation
Current Drug Targets Hyaluronan as an Ophthalmic Viscoelastic Device
Current Pharmaceutical Biotechnology Recent Updates on Development of Drug Molecules for Human African Trypanosomiasis
Current Topics in Medicinal Chemistry Neuromodulation of the Perinatal Respiratory Network
Current Neuropharmacology Parkinson’s Disease: Is there a Role for Dietary and Herbal Supplements?
CNS & Neurological Disorders - Drug Targets Modulation of Aquaporins by Dietary Patterns and Plant Bioactive Compounds
Current Medicinal Chemistry